Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-01-20 00:00:00 ET · period of report 2026-01-20 · accession 0001628280-26-002735 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-20 | 2026-01-20 | MDGL | Taub Rebecca | Dir | S - Sale | $490.77 | -2,238 | 453.4K | -0.5% | -$1.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | S | D | 2,238 | $490.77 | 453,351 | D | — | — |